The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Pharmacokinetics of piperacillin and tazobactam in plasma and subcutaneous interstitial fluid in critically ill patients receiving continuous venovenous haemodiafiltration
Burns, Trauma & Critical Care Research Centre, The University of Queensland, Level 7, Block 6, Royal Brisbane and Women’s Hospital, Brisbane, QLD 4029, Australia
Burns, Trauma & Critical Care Research Centre, The University of Queensland, Level 7, Block 6, Royal Brisbane and Women’s Hospital, Brisbane, QLD 4029, Australia
Department of Intensive Care Medicine, Level 3, Ned Hanlon Building, Royal Brisbane and Women’s Hospital, Brisbane, QLD 4029, Australia
Burns, Trauma & Critical Care Research Centre, The University of Queensland, Level 7, Block 6, Royal Brisbane and Women’s Hospital, Brisbane, QLD 4029, Australia
Department of Intensive Care Medicine, Level 3, Ned Hanlon Building, Royal Brisbane and Women’s Hospital, Brisbane, QLD 4029, Australia
Pharmacy Department, Level 1, Ned Hanlon Building, Royal Brisbane & Women’s Hospital, Brisbane, QLD 4029, Australia
Burns, Trauma & Critical Care Research Centre, The University of Queensland, Level 7, Block 6, Royal Brisbane and Women’s Hospital, Brisbane, QLD 4029, Australia
Department of Intensive Care Medicine, Level 3, Ned Hanlon Building, Royal Brisbane and Women’s Hospital, Brisbane, QLD 4029, Australia